Skip to main contentSkip to navigation
Sirius Investors
Seelos Therapeutics, Inc.

Seelos Therapeutics, Inc.

SEEL
NASDAQHealthcare

SEEL Financial Statements & Analysis

Complete financial statements for SEEL including income statement, balance sheet, and cash flow statement. Analyze SEEL's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
2.0%
Net Income
115.1%
Gross Margin
-37.8%
Operating Margin
22.3%

Balance Sheet

Current Ratio
-20.9%
Debt to Equity
9.0%
Asset Turnover
54.8%

Cash Flow

Operating Cash Flow
27.1%
Net Cash Flow
59.0%
Free Cash Flow
27.1%
Cash Flow to Debt
5.7%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '24TTM Q2 '24ChangeImpact
Revenue1.97M2.01M2.0%
Gross Profit1.92M1.22M36.6%
Operating Income-37.62M-29.81M20.8%
Net Income-27.11M4.09M115.1%
EPS-1.850.37119.9%
EBITDA-26.97M4.26M115.8%
Gross Margin97.06%60.33%37.8%
Operating Margin-1905.88%-1480.04%22.3%
Net Income Margin-1373.61%203.13%114.8%
R&D Expenses27.97M20.43M27.0%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '24TTM Q1 '24TTM Q4 '23TTM Q3 '23TTM Q2 '23
Revenue2.01M1.97M2.20M
Gross Profit1.22M1.92M2.15M
Operating Income-29.81M-37.62M-40.50M
Net Income4.09M-27.11M-41.70M
EPS0.37-1.85-2.68
EBITDA4.26M-26.97M-37.75M
Gross Margin60.33%97.06%97.41%
Operating Margin-1480.04%-1905.88%-1838.36%
Net Income Margin203.13%-1373.61%-1892.83%
R&D Expenses20.43M27.97M30.12M

Our detailed financial analysis helps investors understand SEEL's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track SEEL's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into SEEL's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Seelos Therapeutics, Inc. (SEEL) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors